Cargando…

Therapeutic Significance of microRNA-Mediated Regulation of PARP-1 in SARS-CoV-2 Infection

The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 (2019-nCoV) has devastated global healthcare and economies. Despite the stabilization of infectivity rates in some developed nations, several countries are still under the grip of the pathogenic viral mutants that are causing a signifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dash, Sabyasachi, Dash, Chandravanu, Pandhare, Jui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544662/ https://www.ncbi.nlm.nih.gov/pubmed/34698261 http://dx.doi.org/10.3390/ncrna7040060

Ejemplares similares

Are microRNAs Important Players in HIV-1 Infection? An Update
por: Balasubramaniam, Muthukumar, et al.
Publicado: (2018)

Activation of proline metabolism maintains ATP levels during cocaine-induced polyADP-ribosylation
por: Dash, Sabyasachi, et al.
Publicado: (2021)

Impact of cocaine abuse on HIV pathogenesis
por: Dash, Sabyasachi, et al.
Publicado: (2015)

Poly (ADP-Ribose) Polymerase-1 (PARP-1) Induction by Cocaine Is Post-Transcriptionally Regulated by miR-125b
por: Dash, Sabyasachi, et al.
Publicado: (2017)

Cocaine-regulated microRNA miR-124 controls poly (ADP-ribose) polymerase-1 expression in neuronal cells
por: Dash, Sabyasachi, et al.
Publicado: (2020)

Correction: Cocaine Enhances HIV-1 Replication in CD4+ T Cells by Down-Regulating MiR-125b
por: Mantri, Chinmay K., et al.
Publicado: (2018)

A Novel Role of Prolidase in Cocaine-Mediated Breach in the Barrier of Brain Microvascular Endothelial Cells
por: Ysrayl, Binah baht, et al.
Publicado: (2019)

Cocaine Enhances HIV-1 Replication in CD4+ T Cells by Down-Regulating MiR-125b
por: Mantri, Chinmay K., et al.
Publicado: (2012)

Cocaine Enhances HIV-1 Transcription in Macrophages by Inducing p38 MAPK Phosphorylation
por: Swepson, Chelsie, et al.
Publicado: (2016)

Downregulation of APOBEC3G by xenotropic murine leukemia-virus related virus (XMRV) in prostate cancer cells
por: Dey, Abhinav, et al.
Publicado: (2011)

PROLIDASE: A Review from Discovery to its Role in Health and Disease
por: Eni-Aganga, Ireti, et al.
Publicado: (2021)

Phycobilins as Potent Food Bioactive Broad-Spectrum Inhibitors Against Proteases of SARS-CoV-2 and Other Coronaviruses: A Preliminary Study
por: Pendyala, Brahmaiah, et al.
Publicado: (2021)

Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1
por: Renrick, Ariana N., et al.
Publicado: (2021)

Activation of proline biosynthesis is critical to maintain glutamate homeostasis during acute methamphetamine exposure
por: Jones, Bobby, et al.
Publicado: (2021)

Superantigens and SARS-CoV-2
por: Hamdy, Adam, et al.
Publicado: (2022)

HIV-1 mutants that escape the cytotoxic T-lymphocytes are defective in viral DNA integration
por: Balasubramaniam, Muthukumar, et al.
Publicado: (2022)

MicroRNA-based therapeutics for optic neuropathy: opportunities and challenges
por: Mak, Heather K., et al.
Publicado: (2021)

Response to “Quantitative Clinical Pharmacology INPUT to SARS‐CoV‐2 Therapeutics Should be Based on Robust Data”
por: Garcia‐Cremades, Maria, et al.
Publicado: (2020)

Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5’UTR of SARS-CoV-2
por: Baldassarre, Antonella, et al.
Publicado: (2020)

Equitable distribution of SARS-CoV-2 tests
por: Garcia-Bereguiain, Miguel Angel, et al.
Publicado: (2022)

SARS-CoV-2 and Arthropods: A Review
por: Higgs, Stephen, et al.
Publicado: (2022)

SARS-CoV-2 S Glycoprotein Stabilization Strategies
por: Pedenko, Borys, et al.
Publicado: (2023)

Bioengineered angiotensin-converting-enzyme-2: a potential therapeutic option against SARS-CoV-2 infection
por: Maiti, Biplab K.
Publicado: (2021)

Approaches and Challenges in SARS-CoV-2 Vaccine Development
por: Dagotto, Gabriel, et al.
Publicado: (2020)

Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
por: Burtscher, Johannes, et al.
Publicado: (2020)

SARS-CoV-2 Vaccines in Patients With Multiple Myeloma
por: Gavriatopoulou, Maria, et al.
Publicado: (2021)

Environmental factors and their role in the transmission of SARS-CoV-2
por: Maciorowski, Dawid, et al.
Publicado: (2021)

Adapting Serosurveys for the SARS-CoV-2 Vaccine Era
por: Duarte, Nathan, et al.
Publicado: (2021)

SARS‐CoV‐2 Omicron variant: Characteristics and prevention
por: He, Xuemei, et al.
Publicado: (2021)

Innate Immune Response in SARS-CoV-2 Infection
por: Schiuma, Giovanna, et al.
Publicado: (2022)

SARS-CoV-2 and probable lung cancer risk
por: Khiali, Sajad, et al.
Publicado: (2022)

What SARS-CoV-2 does to our brains
por: Aschman, Tom, et al.
Publicado: (2022)

Back to Science in Searching for SARS-CoV-2 Origins
por: Liu, William J, et al.
Publicado: (2023)

MicroRNA‐mediated metabolic reprogramming of chimeric antigen receptor T cells
por: Rad, Seyed Mohammad Ali Hosseini, et al.
Publicado: (2022)

The Recombination Potential between SARS-CoV-2 and MERS-CoV from Cross-Species Spill-over Infections
por: Sajini, Abdulrahim A., et al.
Publicado: (2021)

Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection
por: Saçar Demirci, Müşerref Duygu, et al.
Publicado: (2020)

Heat Treatment Promotes Ubiquitin-Mediated Proteolysis of SARS-CoV-2 RNA Polymerase and Decreases Viral Load
por: Maimaitiyiming, Yasen, et al.
Publicado: (2022)

The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection
por: Hu, Jiulue, et al.
Publicado: (2021)

All Surfaces Are Not Equal in Contact Transmission of SARS-CoV-2
por: Xue, Xuan, et al.
Publicado: (2020)

Role of the early secretory pathway in SARS-CoV-2 infection
por: Sicari, Daria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b4cfuh72md3q07s430qepusnj6